Evidence map›Paper›PMID 25749885›Full record

ReviewJournal of neural transmission (Vienna, Austria : 1996)2016

Mitochondrial mechanisms of redox cycling agents implicated in Parkinson's disease.

Pamela Lopert, Manisha Patel

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neural transmission (Vienna, Austria : 1996), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Alpha-Mangostin Alleviates Mitochondrial Damage and Autophagy Dysregulation in the MPPAdvances in pharmacological and pharmaceutical sciences · 2025
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Pamela LopertUniversity of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Manisha PatelUniversity of Colorado Anschutz Medical Campus, Aurora, CO, USA. manisha.patel@ucdenver.edu.
University of Colorado Anschutz Medical Campus · US

Funding

Mitochondrial mechanisms of redox cycling agentsR01NS045748 · NINDS · UNIVERSITY OF COLORADO DENVER · PI PATEL, MANISHA N · 2004 to 2013
$2.6M
NEUROSCIENCE TRAINING GRANTT32HD041697 · NICHD · UNIVERSITY OF COLORADO DENVER · PI RESTREPO, DIEGO · 2001 to 2015
$2.4M
Neuroscience Training GrantT32NS099042 · NINDS · UNIVERSITY OF COLORADO DENVER · PI Nidia Calero, GIDON S FELSEN · 2016 to 2026
$2.1M
NICHD NIH HHS T32 HD041697NINDS NIH HHS R01 NS045748NINDS NIH HHS T32 NS099042
6 · The paper itself

Abstract

Environmental agents have been implicated in Parkinson's disease (PD) based on epidemiological studies and the ability of toxicants to replicate features of PD. However, the precise mechanisms by which toxicants induce dopaminergic toxicity observed in the idiopathic form of PD remain to be fully understood. The roles of ROS and mitochondria are strongly suggested in the mechanisms by which these toxicants exert dopaminergic toxicity. There are marked differences and similarities shared by the toxicants in increasing steady-state levels of mitochondrial ROS. Furthermore, toxicants increase steady-state mitochondrial ROS levels by stimulating the production, inhibiting the antioxidant pathways of both. This review will focus on the role of mitochondria and ROS in PD associated with environmental exposures to redox-based toxicants.

Indexed as

AnimalsHumansMitochondriaOxidation-ReductionParkinson DiseaseAntioxidantsMitochondriaParkinson's diseasePesticidesReactive oxygen speciesRedox-cycling

Identifiers

PMID25749885
PMCPMC5049695
OpenAlexW2082812344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.